Johnson & Johnson Innovation has announced a collaboration with the Shanghai municipal government, Pudong New Area government, and Shanghai Pharma Engine Company to launch a new Johnson & Johnson Innovation, JLABS in Shanghai. The 4,400 square meter facility will be located in Shanghai's Zhangjiang Hi-Tech Park and will open in the second quarter of 2019.
JLABS @ Shanghai will be the first JLABS location established outside of North America and will accommodate up to 50 life science and healthcare startups, both single entrepreneurs and larger companies, focused on innovations across the entire healthcare spectrum, including pharmaceuticals, medical devices and consumer. JLABS @ Shanghai will provide resident innovators with a capital efficient and flexible platform including an extensive network that will enable them to accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients in China and around the world.
"We are excited about the launch of JLABS @ Shanghai, which will be an integral investment in the city's life science ecosystem. It will support entrepreneurship as it relates to science and technology and strengthen our position as a global innovation hub," said Liu Qin, deputy inspector general, science and technology commission, Shanghai municipal government.